Literature DB >> 12466042

Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action.

Chiu-Yin Kwan1, F I Achike.   

Abstract

Tetrandrine (TET), a bis-benzylisoquinoline alkaloid purified and identified an active ingredient in a Chinese medicinal herb, radix stephanae tetrandrae, has been used traditionally for the treatment of congestive circulatory disorder and inflammatory diseases. TET, together with a few of its structural analogues, has long been demonstrated to have antihypertensive action in clinical as well as animal studies. Presumably, the primary anti-hypertensive action of TET is due to its vasodilatory properties. TET prevents or inhibits vascular contraction induced by membrane depolarization with KCl or alpha-adrenoceptor activation with phenylephrine (PE). TET (30 micromol/L) also inhibits the release of endothelium-derived nitric oxide (NO) as well as NO production by inducible NO synthase. TET apparently inhibits multiple Ca2+ entry pathways as demonstrated in cell types lacking the L-type Ca2+ channels. In cardiac muscle cells, TET inhibits both L- and T-type Ca2+ channels. In addition to its actions on cardiovascular tissues, TET may also exert its anti-hypertensive action via a Ca2+-dependent manner on other tissues intimately involved in the modulation of blood pressure control, such as adrenal glands. In adrenal glomerulosa cells, KCl- or angiotensin II-induced aldosterone synthesis is highly dependent on extracellular Ca2+. Steroidogenesis and Ca2+-influx in bovine adrenal glomerulosa cells have been shown to be potently inhibited by TET. In bovine adrenal chromaffin cells, TET inhibits Ca2+ currents via L- and N-type channels as well as other unidentified channels with IC50 of 10 micromol/L. Other than the Ca2+ antagonistic effects, TET also interacts with the alpha-adrenergic receptors and muscarinic receptors based on functional as well as radioligand binding studies. Apart from its functional effects, TET and related compounds also exert effects on tissue structures, such as remodelling of hypertrophied heart and inhibition of angiogenesis, probably by causing apoptotic responses. TET is also known for its anti-inflammatory and anti-fibrogenic actions, which make TET and related compound potentially useful in the treatment of lung silicosis, liver cirrhosis, and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466042

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  22 in total

1.  Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Authors:  Yasuteru Sakurai; Andrey A Kolokoltsov; Cheng-Chang Chen; Michael W Tidwell; William E Bauta; Norbert Klugbauer; Christian Grimm; Christian Wahl-Schott; Martin Biel; Robert A Davey
Journal:  Science       Date:  2015-02-27       Impact factor: 47.728

2.  Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae.

Authors:  Kristy M Hawkins; Christina D Smolke
Journal:  Nat Chem Biol       Date:  2008-09       Impact factor: 15.040

3.  JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.

Authors:  Jun-Ting Liou; Chin-Sheng Lin; Yu-Cheng Liao; Ling-Jun Ho; Shih-Ping Yang; Jenn-Haung Lai
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

Review 4.  Engineering microbial factories for synthesis of value-added products.

Authors:  Jing Du; Zengyi Shao; Huimin Zhao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-04-28       Impact factor: 3.346

5.  In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel).

Authors:  Wen-Bo Zhang; Chang-Xun Chen; Si-Mui Sim; Chiu-Yin Kwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-11       Impact factor: 3.000

6.  BIAdb: a curated database of benzylisoquinoline alkaloids.

Authors:  Deepak Singla; Arun Sharma; Jasjit Kaur; Bharat Panwar; Gajendra P S Raghava
Journal:  BMC Pharmacol       Date:  2010-03-05

7.  Endothelium-dependent vascular relaxation induced by Eucommia ulmoides Oliv. bark extract is mediated by NO and EDHF in small vessels.

Authors:  Chiu-Yin Kwan; Wen-Bo Zhang; Takeshi Deyama; Sansei Nishibe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-13       Impact factor: 3.000

8.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

9.  Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.

Authors:  Junrong Song; Junjie Lan; Chao Chen; Shengcao Hu; Jialei Song; Wulin Liu; Xueyi Zeng; Huayong Lou; Yaacov Ben-David; Weidong Pan
Journal:  Medchemcomm       Date:  2018-05-04       Impact factor: 3.597

10.  Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

Authors:  Di-Fei Shen; Qi-Zhu Tang; Ling Yan; Yan Zhang; Li-Hua Zhu; Lang Wang; Chen Liu; Zhou-Yan Bian; Hongliang Li
Journal:  Br J Pharmacol       Date:  2010-01-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.